Prana Biotechnology Quote - PBT

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

0.049

Bid

0.047

Ask

0.05

Volume

0.00

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Previous Close

0.049

Open

Last Trade

Last Trade Time

Average Volume (3m)

Financial Volume

VWAP

Alterity Therapeutics Launches to Asian Investors

Alterity Therapeutics Limited, (formerly Prana Biotechnology Limited) (ASX: PBT, NASDAQ: ATHE) (“Alterity” or “the Company”) is meeting this week with sophisticated investors in both...

Prana Receives First Orphan Drug Designation from the FDA for the Treatment of Multiple System Atrophy

Prana Biotechnology Ltd (ASX: PBT, NASDAQ: PRAN) (“Prana” or “the Company”) has today announced the US Food and Drug Administration (FDA) has granted Orphan Drug designation for its lead...

Prana Biotechnology: Pre-Clinical Evidence Demonstrates PBT434 as a Potential Treatment for MSA

PBT434 prevents alpha-synuclein aggregation, preserves neurons, reduces glial cell inclusions and slows motor dysfunction in an animal model of Multiple System Atrophy Prana Biotechnology...

PBT434 Data to be Presented at the International Congress of Parkinson’s Disease and Movement Disorders

Prana’s PBT434 prevents neuronal loss in a new model of neurodegeneration Prana Biotechnology Ltd (ASX PBT: NASDAQ PRAN) has today announced it will be presenting further pre-clinical...

First Volunteers Dosed in Phase I Clinical Trial of PBT434, Prana’s Lead Therapy for Parkinsonian Diseases

Highlights: Prana enrols and doses its first cohort of healthy volunteers in its Phase I clinical trial Evidence supports activity of PBT434 to prevent α-synuclein accumulation...

Prana to Commence Phase 1 Clinical Trial of PBT434 for Treatment of Parkinsonian Diseases

Highlights: Prana receives ethics committee approval for a clinical trial evaluating first in human dosing of PBT434 Recruitment has commenced for the first cohort of healthy...

Prana Commences Research Collaboration with Takeda for the Treatment of Parkinson's Disease Gastrointestinal Neuropathology

PBT434, Prana’s lead drug in preclinical development for movement disorders, to be profiled in collaborative venture Prana Biotechnology Ltd (ASX:PBT)(NASDAQ:PRAN) today announced a...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

PBT - Frequently Asked Questions (FAQ)

What is the current Prana Biotechnology share price?

The current share price of Prana Biotechnology is AUD 0.049

What is the 1 year trading range for Prana Biotechnology share price?

Prana Biotechnology has traded in the range of AUD 0.00 to AUD 0.00 during the past year

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
QEMOQEM Limited	AUD 0.009 (80.00%)	118.15k
ETMEnergy Transition Minerals Ltd	AUD 0.08 (60.00%)	33.64M
AMSOAtomos Limited	AUD 0.003 (50.00%)	114.29k
RLCReedy Lagoon Corporation Limited	AUD 0.003 (50.00%)	3.27k
AUZAustralian Mines Limited	AUD 0.012 (50.00%)	27.82M
EM2REagle Mountain Mining Limited	AUD 0.001 (-50.00%)	950k
FRXFlexiroam Limited	AUD 0.006 (-40.00%)	7.99M
RR1OAReach Resources Ltd	AUD 0.002 (-33.33%)	39.33k
AYMAustralia United Mining Limited	AUD 0.003 (-25.00%)	213.64k
TVNOTivan Ltd	AUD 0.015 (-25.00%)	2k
MEKMeeka Metals Ltd	AUD 0.095 (9.20%)	64.94M
GCMGreen Critical Minerals Ltd	AUD 0.018 (-5.26%)	59.48M
TMGTrigg Minerals Ltd	AUD 0.051 (6.25%)	39.9M
SYASayona Mining Limited	AUD 0.0265 (-3.64%)	39.27M
RDNRaiden Resources Limited	AUD 0.014 (33.33%)	34.73M